Chapel Hill-based drug company Pozen Inc. has earned a $10 million milestone payment in its ongoing development of an arthritis treatment called Vimovo. (AZN)

Lees meer..

New York plans to invest $20.4 million in stem-cell research.

Lees meer..

Positive drug trial results? Check. More than $125 million in four financings during a life sciences industry funding drought? Check. And yet, those things mark just the beginning for Micromet Inc., a Bethesda biotech that aims to enter what is the most grueling and coveted terrain for any drug developer next year.

Lees meer..

DOYLESTOWN — Every year in the United States, more than 1.4 million people suffer a heart attack — and 650,000 people do not survive.

Lees meer..

A collaboration between two professors at the University of Memphis and Southern College of Optometry could result in earlier detection of retinal diseases through a patent-pending testing process.

Lees meer..

Cardiologists in Greensboro are uniting for the first time to protest proposed Medicare payment cuts.

Lees meer..

The N.C. Center of Innovation for Nanobiotechnology or NC-COIN, a collaborative project of the Triad’s three public and private research universities, has chosen the Triangle as the location of its new office.

Lees meer..

As president of Peace College, it’s Laura Bingham’s job to ensure that each woman who enters the campus is educated and prepared to take on the world. if they’re trying to emulate Bingham, Peace students have found a good role model.

Lees meer..

Silicon Valley biotech companies emerging from the incubator stage face an unusual real estate market in their hunt for space. While life science vacancies are high right now, there is not much startup lab space to be found.

Lees meer..

New England Biolabs spinoff BioHelix Corp. is leaving the nest and establishing its own headquarters after five years under its parent’s wing.

Lees meer..